Literature DB >> 24357728

A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin.

Airie Kim1, Eileen Fung, Sona G Parikh, Erika V Valore, Victoria Gabayan, Elizabeta Nemeth, Tomas Ganz.   

Abstract

Anemia is a common complication of infections and inflammatory diseases, but the few mouse models of this condition are not well characterized. We analyzed in detail the pathogenesis of anemia induced by an injection of heat-killed Brucella abortus and examined the contribution of hepcidin by comparing wild-type (WT) to iron-depleted hepcidin-1 knockout (Hamp-KO) mice. B abortus-treated WT mice developed severe anemia with a hemoglobin nadir at 14 days and partial recovery by 28 days. After an early increase in inflammatory markers and hepcidin, WT mice manifested hypoferremia, despite iron accumulation in the liver. Erythropoiesis was suppressed between days 1 and 7, and erythrocyte destruction was increased as evidenced by schistocytes on blood smears and shortened red blood cell lifespan. Erythropoietic recovery began after 14 days but was iron restricted. In B abortus-treated Hamp-KO compared with WT mice, anemia was milder, not iron restricted, and had a faster recovery. Similarly to severe human anemia of inflammation, the B abortus model shows multifactorial pathogenesis of inflammatory anemia including iron restriction from increased hepcidin, transient suppression of erythropoiesis, and shortened erythrocyte lifespan. Ablation of hepcidin relieves iron restriction and improves the anemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24357728     DOI: 10.1182/blood-2013-08-521419

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  Iron homeostasis: An anthropocentric perspective.

Authors:  Richard Coffey; Tomas Ganz
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

Review 2.  Anemia of Inflammation: A Review.

Authors:  Paula G Fraenkel
Journal:  Med Clin North Am       Date:  2016-12-24       Impact factor: 5.456

3.  Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.

Authors:  Mark R Hanudel; Kristine Chua; Maxime Rappaport; Victoria Gabayan; Erika Valore; David Goltzman; Tomas Ganz; Elizabeta Nemeth; Isidro B Salusky
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-12

Review 4.  Iron and inflammation - the gut reaction.

Authors:  Smriti Verma; Bobby J Cherayil
Journal:  Metallomics       Date:  2017-02-22       Impact factor: 4.526

Review 5.  Anemia of inflammation.

Authors:  Elizabeta Nemeth; Tomas Ganz
Journal:  Hematol Oncol Clin North Am       Date:  2014-05-28       Impact factor: 3.722

6.  Critical models for the anemia of inflammation.

Authors:  Paula G Fraenkel
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

Review 7.  Iron and infection.

Authors:  Tomas Ganz
Journal:  Int J Hematol       Date:  2017-11-16       Impact factor: 2.490

Review 8.  The pathophysiology and pharmacology of hepcidin.

Authors:  Piotr Ruchala; Elizabeta Nemeth
Journal:  Trends Pharmacol Sci       Date:  2014-02-17       Impact factor: 14.819

9.  Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.

Authors:  Oleh Akchurin; Angara Sureshbabu; Steve B Doty; Yuan-Shan Zhu; Edwin Patino; Susanna Cunningham-Rundles; Mary E Choi; Adele Boskey; Stefano Rivella
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-20

Review 10.  Stress erythropoiesis: definitions and models for its study.

Authors:  Robert F Paulson; Sneha Hariharan; Jane A Little
Journal:  Exp Hematol       Date:  2020-08-02       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.